[Blood coagulation disorders in hepatitis and their therapy].
D000614:Aminocaproates / Q000627:therapeutic use; D001778:Blood Coagulation Disorders / Q000209:etiology / Q000628:therapy*; D001779:Blood Coagulation Factors / Q000096:biosynthesis / Q000627:therapeutic use; D002779:Cholestasis / Q000150:complications; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D005338:Fibrin Fibrinogen Degradation Products; D006493:Heparin / Q000627:therapeutic use; D006505:Hepatitis / Q000150:complications*; D006801:Humans; D008102:Liver Circulation; D014812:Vitamin K / Q000627:therapeutic use
D000614:Aminocaproates; D001779:Blood Coagulation Factors; D005338:Fibrin Fibrinogen Degradation Products; D014812:Vitamin K; D006493:Heparin
Gerinnungsstörungen bei Hepatitis und deren Therapie